Cargando…

Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial

BACKGROUND: The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Awori, Quentin, Li, Philip S., Lee, Richard K., Ouma, Daniel, Oundo, Millicent, Barasa, Mukhaye, Obura, Nereah, Mwamkita, David, Simba, Raymond, Oketch, Jairus, Nyangweso, Nixon, Maina, Mary, Kiswi, Nicholas, Kirui, Michael, Chirchir, Betty, Goldstein, Marc, Barone, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693766/
https://www.ncbi.nlm.nih.gov/pubmed/31412032
http://dx.doi.org/10.1371/journal.pone.0218066
_version_ 1783443734761832448
author Awori, Quentin
Li, Philip S.
Lee, Richard K.
Ouma, Daniel
Oundo, Millicent
Barasa, Mukhaye
Obura, Nereah
Mwamkita, David
Simba, Raymond
Oketch, Jairus
Nyangweso, Nixon
Maina, Mary
Kiswi, Nicholas
Kirui, Michael
Chirchir, Betty
Goldstein, Marc
Barone, Mark A.
author_facet Awori, Quentin
Li, Philip S.
Lee, Richard K.
Ouma, Daniel
Oundo, Millicent
Barasa, Mukhaye
Obura, Nereah
Mwamkita, David
Simba, Raymond
Oketch, Jairus
Nyangweso, Nixon
Maina, Mary
Kiswi, Nicholas
Kirui, Michael
Chirchir, Betty
Goldstein, Marc
Barone, Mark A.
author_sort Awori, Quentin
collection PubMed
description BACKGROUND: The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcision (VMMC) has been shown to dramatically reduce the risk of HIV acquisition in males. However, the fear of pain during circumcision is an important barrier to uptake. Use of topical anesthesia thus presents an opportunity to address this. OBJECTIVES: We sought to evaluate the safety, effectiveness and acceptability of the use of topical anaesthesia with ShangRing circumcision of men and boys 10 years of age and above. METHODS: Participants were randomised 2:1 to receive topical or injectable anaesthesia. All participants underwent no-flip ShangRing circumcision. The primary outcome measure was pain. Secondary outcomes included ease of use of topical versus injectable anaesthesia, AEs and participant satisfaction. RESULTS: Compared to the topical group, participants in the injectable group reported significantly more pain on administration of the anesthesia and at approximately 20 minutes after the procedure. In the topical group, sufficient anaesthesia with topical cream was not achieved in 21 (9.3%) cases before the start of the procedure; in another 6 (2.6%), supplementary injectable anaesthesia was required as the circumcision was being carried out. The AE rate was significantly lower (p<0.01) in the topical (0%) vs. the injectable group (4.2%). The most common AE was pain during the post-operative period. All AEs were managed conservatively and resolved without sequeale. 96.7% of participants were satisfied with the appearance of the healed penis and 100% would recommend the ShangRing to others. All seven male circumcision providers involved in the study preferred topical to injectable anaesthesia. CONCLUSIONS: Our results demonstrate the safety, improved clinical experience, effectiveness, and acceptability of the use of topical anaesthesia in ShangRing circumcision using the no-flip technique. Topical anaesthesia effectively eliminates needlestick pain from the clients’ VMMC experience and thus has the potential to increase demand for the service. TRIAL REGISTRATION: ClinicalTrials.gov NCT02390310.
format Online
Article
Text
id pubmed-6693766
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66937662019-08-16 Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial Awori, Quentin Li, Philip S. Lee, Richard K. Ouma, Daniel Oundo, Millicent Barasa, Mukhaye Obura, Nereah Mwamkita, David Simba, Raymond Oketch, Jairus Nyangweso, Nixon Maina, Mary Kiswi, Nicholas Kirui, Michael Chirchir, Betty Goldstein, Marc Barone, Mark A. PLoS One Research Article BACKGROUND: The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcision (VMMC) has been shown to dramatically reduce the risk of HIV acquisition in males. However, the fear of pain during circumcision is an important barrier to uptake. Use of topical anesthesia thus presents an opportunity to address this. OBJECTIVES: We sought to evaluate the safety, effectiveness and acceptability of the use of topical anaesthesia with ShangRing circumcision of men and boys 10 years of age and above. METHODS: Participants were randomised 2:1 to receive topical or injectable anaesthesia. All participants underwent no-flip ShangRing circumcision. The primary outcome measure was pain. Secondary outcomes included ease of use of topical versus injectable anaesthesia, AEs and participant satisfaction. RESULTS: Compared to the topical group, participants in the injectable group reported significantly more pain on administration of the anesthesia and at approximately 20 minutes after the procedure. In the topical group, sufficient anaesthesia with topical cream was not achieved in 21 (9.3%) cases before the start of the procedure; in another 6 (2.6%), supplementary injectable anaesthesia was required as the circumcision was being carried out. The AE rate was significantly lower (p<0.01) in the topical (0%) vs. the injectable group (4.2%). The most common AE was pain during the post-operative period. All AEs were managed conservatively and resolved without sequeale. 96.7% of participants were satisfied with the appearance of the healed penis and 100% would recommend the ShangRing to others. All seven male circumcision providers involved in the study preferred topical to injectable anaesthesia. CONCLUSIONS: Our results demonstrate the safety, improved clinical experience, effectiveness, and acceptability of the use of topical anaesthesia in ShangRing circumcision using the no-flip technique. Topical anaesthesia effectively eliminates needlestick pain from the clients’ VMMC experience and thus has the potential to increase demand for the service. TRIAL REGISTRATION: ClinicalTrials.gov NCT02390310. Public Library of Science 2019-08-14 /pmc/articles/PMC6693766/ /pubmed/31412032 http://dx.doi.org/10.1371/journal.pone.0218066 Text en © 2019 Awori et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Awori, Quentin
Li, Philip S.
Lee, Richard K.
Ouma, Daniel
Oundo, Millicent
Barasa, Mukhaye
Obura, Nereah
Mwamkita, David
Simba, Raymond
Oketch, Jairus
Nyangweso, Nixon
Maina, Mary
Kiswi, Nicholas
Kirui, Michael
Chirchir, Betty
Goldstein, Marc
Barone, Mark A.
Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
title Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
title_full Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
title_fullStr Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
title_full_unstemmed Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
title_short Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
title_sort use of topical versus injectable anaesthesia for shangring circumcisions in men and boys in kenya: results from a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693766/
https://www.ncbi.nlm.nih.gov/pubmed/31412032
http://dx.doi.org/10.1371/journal.pone.0218066
work_keys_str_mv AT aworiquentin useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT liphilips useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT leerichardk useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT oumadaniel useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT oundomillicent useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT barasamukhaye useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT oburanereah useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT mwamkitadavid useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT simbaraymond useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT oketchjairus useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT nyangwesonixon useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT mainamary useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT kiswinicholas useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT kiruimichael useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT chirchirbetty useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT goldsteinmarc useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial
AT baronemarka useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial